<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml">
	<head>
		<meta charset="utf-8" />
		<title>BCSC1718_S05_ch00FM_pi-xvi</title>
		<link href="BCSC1718_S05_ch00FM_pi-xvi-web-resources/css/idGeneratedStyles.css" rel="stylesheet" type="text/css" />
	</head>
	<body id="BCSC1718_S05_ch00FM_pi-xvi" lang="en-US">
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer000" class="_idGenObjectStyleOverride-1">
				<img class="_idGenObjectAttribute-1" src="BCSC1718_S05_ch00FM_pi-xvi-web-resources/image/AAO_med_full_clr_c_cmyk.png" alt="" />
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer001" class="_idGenObjectStyleOverride-1">
				<img class="_idGenObjectAttribute-1" src="BCSC1718_S05_ch00FM_pi-xvi-web-resources/image/AAO_tag_gray_c_cmyk.png" alt="" />
			</div>
		</div>
		<div id="_idContainer002" class="Basic-Text-Frame">
			<p class="NEW-Title"><span class="CharOverride-1">Neuro-Ophthalmology</span></p>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer003" class="Basic-Graphics-Frame _idGenObjectStyleOverride-2">
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer004" class="Basic-Graphics-Frame _idGenObjectStyleOverride-2">
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer005" class="Basic-Text-Frame">
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer006" class="Basic-Graphics-Frame _idGenObjectStyleOverride-2">
			</div>
		</div>
		<div id="_idContainer007" class="Basic-Graphics-Frame _idGenObjectStyleOverride-1">
			<p class="BCSC-Spelled-Out---Cover ParaOverride-1"><span class="CharOverride-2"> </span><span class="CharOverride-2">BCSC</span></p>
			<p class="BCSC-Spelled-Out---Cover"><span class="CharOverride-3"> </span><span class="CharOverride-3">Basic and Clinical</span></p>
			<p class="BCSC-Spelled-Out---Cover"><span class="CharOverride-3"> </span><span class="CharOverride-3">Science Course</span><span class="CharOverride-4">™</span></p>
		</div>
		<div id="_idContainer008" class="Basic-Text-Frame">
			<p class="Year---Cover ParaOverride-2"><span class="CharOverride-5">2017–2018</span></p>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer009" class="_idGenObjectStyleOverride-1">
				<img class="_idGenObjectAttribute-1" src="data:image/jpg;base64,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" alt="" />
			</div>
		</div>
		<div id="_idContainer010" class="Basic-Text-Frame">
			<p class="Basic-Paragraph ParaOverride-3"><span class="CharOverride-6">5</span></p>
		</div>
		<div id="_idContainer011" class="Basic-Text-Frame">
			<p class="fm-tp--pub-rev-date-"><span class="CharOverride-7">Published after collaborative <br />review with the European Board <br />of Ophthalmology subcommittee</span></p>
		</div>
		<div id="_idContainer014" class="_idGenObjectStyleOverride-1">
			<p class="fm-only_fm-copyright-cme-text">The American Academy of Ophthalmology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.</p>
			<p class="fm-only_fm-copyright-cme-text ParaOverride-4">The American Academy of Ophthalmology designates this enduring material for a maximum of 15 <span class="CharOverride-8">AMA PRA Category 1 Credits</span><span class="CharOverride-9">™</span>. Physicians should claim only the credit commensurate with the extent of their participation in the activity.</p>
			<p class="fm-only_fm-copyright-text">CME expiration date: June&#160;1, 2020. <span class="CharOverride-8">AMA PRA Category 1 Credits</span><span class="CharOverride-10">™</span> may be claimed only once between June 1, 2017, and the expiration date.</p>
			<p class="fm-only_fm-copyright-text">BCSC<span class="CharOverride-9">®</span> volumes are designed to increase the physician’s ophthalmic knowledge through study and review. Users of this activity are encouraged to read the text and then answer the study questions provided at the back of the book.</p>
			<p class="fm-only_fm-copyright-text">To claim <span class="CharOverride-8">AMA PRA Category 1 Credits</span><span class="CharOverride-9">™</span> upon completion of this activity, learners must demonstrate appropriate knowledge and participation in the activity by taking the posttest for Section 5 and achieving a score of 80% or higher. For further details, please see the instructions for requesting CME credit at the back of the book.</p>
			<p class="fm-only_fm-copyright-text">The Academy provides this material for educational purposes only. It is not intended to represent the only or best method or procedure in every case, nor to replace a physician’s own judgment or give specific advice for case management. Including all indications, contraindications, side effects, and alternative agents for each drug or treatment is beyond the scope of this material. All information and recommendations should be verified, prior to use, with current information included in the manufacturers’ package inserts or other independent sources, and considered in light of the patient’s condition and history. Reference to certain drugs, instruments, and other products in this course is made for illustrative purposes only and is not intended to constitute an endorsement of such. Some material may include information on applications that are not considered community standard, that reflect indications not included in approved FDA labeling, or that are approved for use only in restricted research settings. <span class="CharOverride-11">The FDA has stated that it is the responsibility of the physician to determine the FDA status of each drug or device he or she wishes to use, and to use them with appropriate, informed patient consent in compliance with applicable law.</span> The Academy specifically disclaims any and all liability for injury or other damages of any kind, from negligence or otherwise, for any and all claims that may arise from the use of any recommendations or other information contained herein.</p>
			<p class="fm-only_fm-copyright-text">AAO, AAOE, American Academy of Ophthalmology, Basic and Clinical Science Course, BCSC, EyeCare America, EyeNet, EyeSmart, EyeWiki, Focal Points, IRIS, ISRS, OKAP, ONE, Ophthalmic Technology Assessments, <span class="italic">Ophthalmology,</span> Preferred Practice Pattern, ProVision, SmartSight, The Ophthalmic News &amp; Education Network, and the AAO logo (shown on cover) and tagline (Protecting Sight. Empowering Lives.) are, among other marks, the registered trademarks and trademarks of the American Academy of Ophthalmology.</p>
			<p class="fm-only_fm-copyright-text ParaOverride-5">Cover image: Fundus photograph showing an arteriovenous malformation (racemose angioma) of the retina in a patient with Wyburn-Mason syndrome. <span class="CharOverride-8">(Courtesy of Mark J. Greenwald, MD.)</span></p>
			<p class="fm-only_fm-title _idGenParaOverride-1">Basic and Clinical Science Course</p>
			<p class="fm-only_fm-contributors-text">Louis B. Cantor, MD, Indianapolis, Indiana, <span class="CharOverride-8">Senior Secretary for Clinical Education</span></p>
			<p class="fm-only_fm-contributors-text">Christopher J. Rapuano, MD, Philadelphia, Pennsylvania, <span class="CharOverride-8">Secretary for Lifelong Learning and Assessment</span></p>
			<p class="fm-only_fm-contributors-text">George A. Cioffi, MD, New York, New York, <span class="CharOverride-8">BCSC Course Chair</span></p>
			<p class="fm-only_fm-h1">Section 5</p>
			<p class="fm-only_fm-h2">Faculty</p>
			<p class="fm-only_fm-contributors-text">M. Tariq Bhatti, MD, <span class="CharOverride-8">Chair,</span> Durham, North Carolina</p>
			<p class="fm-only_fm-contributors-text">Valerie Biousse, MD, Atlanta, Georgia </p>
			<p class="fm-only_fm-contributors-text">Swaraj Bose, MD, Los Angeles, California</p>
			<p class="fm-only_fm-contributors-text">Julie Falardeau, MD, Portland, Oregon</p>
			<p class="fm-only_fm-contributors-text">Leonard A. Levin, MD, PhD, Montreal, Canada </p>
			<p class="fm-only_fm-contributors-text">Paul H. Phillips, MD, Little Rock, Arkansas</p>
			<p class="fm-only_fm-contributors-text">Zöe R. Williams, MD, Rochester, New York</p>
			<p class="fm-only_fm-contributors-text">Helen V. Danesh-Meyer, MBCHB, MD, <span class="CharOverride-8">Consultant,</span> Auckland, <br />New Zealand</p>
			<p class="fm-only_fm-disclaimers">The Academy wishes to acknowledge the <span class="CharOverride-8">North American Neuro-Ophthalmology Society (NANOS)</span> for recommending faculty members to the BCSC Section 5 committee. </p>
			<p class="fm-only_fm-disclaimers">The Academy also wishes to acknowledge the following committees for review of this edition:</p>
			<p class="fm-only_fm-disclaimers"><span class="CharOverride-8">Committee on Aging: </span>Fiona Costello, MD, Calgary, Canada</p>
			<p class="fm-only_fm-disclaimers"><span class="CharOverride-8">Vision Rehabilitation Committee:</span> William M. McLaughlin Jr, DO, Allentown, Pennsylvania</p>
			<p class="fm-only_fm-disclaimers"><span class="CharOverride-8">Practicing Ophthalmologists Advisory Committee for Education: </span>Steven J. Grosser, MD, <span class="CharOverride-8">Primary Reviewer, </span>Golden Valley, Minnesota;<span class="CharOverride-8"> </span>Edward K. Isbey III, <span class="CharOverride-8">Chair,</span> Asheville, North Carolina; Alice Bashinsky, MD, Asheville, North Carolina; David Browning, MD, PhD, Charlotte, North Carolina; Bradley D. Fouraker, MD, Tampa, Florida; Stephen R. Klapper, MD, Carmel, Indiana; James A. Savage, MD, Memphis, Tennessee; Michelle S. Ying, MD, Ladson, South Carolina</p>
			<p class="fm-only_fm-disclaimers ParaOverride-6"><img class="_idGenObjectAttribute-2" src="data:image/jpg;base64,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" alt="" /></p>
			<p class="fm-only_fm-disclaimers ParaOverride-7"><span class="CharOverride-8">European Board of Ophthalmology:</span> Klara Landau, MD, FEBO, <span class="CharOverride-8">EBO Chair,</span> Zürich, Switzerland; Marko Hawlina, MD, PhD, <span class="CharOverride-8">EBO Liaison,</span> Ljubljana, Slovenia; François-Xavier Borruat, MD, Lausanne, Switzerland; Antonella Boschi, MD, Brussels, Belgium; Michael Anthony Burdon, MBBS, Birmingham, England, United Kingdom; Wolf A. Lagrèze, MD, Freiburg, Germany; Dan Milea, MD, PhD, Angers, France</p>
			<p class="fm-only_fm-h2">Financial Disclosures</p>
			<p class="fm-only_fm-disclaimers">Academy staff members who contributed to the development of this product state that within the 12 months prior to their contributions to this CME activity and for the duration of development, they have had no financial interest in or other relationship with any entity discussed in this course that produces, markets, resells, or distributes ophthalmic health care goods or services consumed by or used in patients, or with any competing commercial product or service.</p>
			<p class="fm-only_fm-disclaimers">The authors and reviewers state that within the 12 months prior to their contributions to this CME activity and for the duration of development, they have had the following financial relationships:<span class="CharOverride-12">*</span></p>
			<p class="fm-only_fm-disclaimers">Dr Bhatti: Alexion (C), Novartis Pharmaceuticals (C, L), Receptos (C)</p>
			<p class="fm-only_fm-disclaimers">Dr Biousse: GenSight Biologics (C)</p>
			<p class="fm-only_fm-disclaimers">Dr Browning: Aerpio Therapeutics (S), Alcon (S), Alimera Sciences (C), Genentech (S), Novartis Pharmaceuticals (S), Ohr Pharmaceutical (S), Pfizer (S), Regeneron Pharmaceuticals (S)</p>
			<p class="fm-only_fm-disclaimers">Dr Danesh-Meyer: Allergan (S)</p>
			<p class="fm-only_fm-disclaimers">Dr Fouraker: Addition Technology (C, L), Alcon (C, L), KeraVision (C, L), OASIS Medical (C, L)</p>
			<p class="fm-only_fm-disclaimers">Dr Grosser: Ivantis (O)</p>
			<p class="fm-only_fm-disclaimers">Dr Isbey: Alcon (S), Allscripts (C), Bausch + Lomb (S), Medflow (C), Oculos Clinical Research (S)</p>
			<p class="fm-only_fm-disclaimers">Dr Landau: Santhera Pharmaceuticals (C)</p>
			<p class="fm-only_fm-disclaimers">Dr Levin: Aerie Pharmaceuticals (C), Allergan (C), Inotek Pharmaceuticals (C), Merz (C), Quark Pharmaceuticals (C), Regenera Pharma (C), Synta Pharmaceuticals (C), Teva Pharmaceutical Industries (C)</p>
			<p class="fm-only_fm-disclaimers">Dr Milea: Alcon (L)</p>
			<p class="fm-only_fm-disclaimers">Dr Savage: Allergan (L)</p>
			<p class="fm-only_fm-disclaimers">The other authors and reviewers state that within the past 12 months prior to their contributions to this CME activity and for the duration of development, they have had no financial interest in or other relationship with any entity discussed in this course that produces, markets, resells, or distributes ophthalmic health care goods or services consumed by or used in patients, or with any competing commercial product or service.</p>
			<p class="fm-only_fm-disclaimers-footnote"><span class="CharOverride-12">*</span>C = consultant fees, paid advisory boards, or fees for attending a meeting; L = lecture fees (honoraria), travel fees, or reimbursements when speaking at the invitation of a commercial sponsor; O = equity ownership/stock options of publicly or privately traded firms (excluding mutual funds) with manufacturers of commercial ophthalmic products or commercial ophthalmic services; P = patents and/or royalties that might be viewed as creating a potential conflict of interest; S = grant support for the past year (all sources) and all sources used for a specific talk or manuscript with no time limitation</p>
			<p class="fm-only_fm-h2">Recent Past Faculty</p>
			<p class="fm-only_fm-contributors-text">Rod Foroozan, MD</p>
			<p class="fm-only_fm-contributors-text">Lynn K. Gordon, MD, PhD</p>
			<p class="fm-only_fm-contributors-text">Aki Kawasaki, MD</p>
			<p class="fm-only_fm-contributors-text">Michael S. Lee, MD</p>
			<p class="fm-only_fm-contributors-text">Prem S. Subramanian, MD, PhD</p>
			<p class="fm-only_fm-acknowledgments-text">In addition, the Academy gratefully acknowledges the contributions of numerous past faculty and advisory committee members who have played an important role in the development of previous editions of the Basic and Clinical Science Course.</p>
			<p class="fm-only_fm-h2">American Academy of Ophthalmology Staff</p>
			<p class="fm-only_fm-contributors-text _idGenParaOverride-1"><span>Dale E. Fajardo, </span><span class="CharOverride-8">Vice President, Education</span></p>
			<p class="fm-only_fm-contributors-text _idGenParaOverride-1"><span>Beth Wilson, </span><span class="CharOverride-8">Director, Continuing Professional Development</span></p>
			<p class="fm-only_fm-contributors-text _idGenParaOverride-1"><span>Ann McGuire, </span><span class="CharOverride-8">Acquisitions and Development Manager</span></p>
			<p class="fm-only_fm-contributors-text _idGenParaOverride-1"><span>Stephanie Tanaka, </span><span class="CharOverride-8">Publications Manager</span></p>
			<p class="fm-only_fm-contributors-text _idGenParaOverride-1"><span>D. Jean Ray, </span><span class="CharOverride-8">Production Manager</span></p>
			<p class="fm-only_fm-contributors-text _idGenParaOverride-1"><span>Kimberly Torgerson, </span><span class="CharOverride-8">Publications Editor</span></p>
			<p class="fm-only_fm-contributors-text _idGenParaOverride-1"><span>Beth Collins, </span><span class="CharOverride-8">Medical Editor</span></p>
			<p class="fm-only_fm-contributors-text _idGenParaOverride-1"><span>Naomi Ruiz, </span><span class="CharOverride-8">Publications Specialist</span></p>
			<p class="fm-only_fm-title _idGenParaOverride-1">General Introduction</p>
			<p class="body-text--no-indent-">The Basic and Clinical Science Course (BCSC) is designed to meet the needs of residents and practitioners for a comprehensive yet concise curriculum of the field of ophthalmology. The BCSC has developed from its original brief outline format, which relied heavily on outside readings, to a more convenient and educationally useful self-contained text. The Academy updates and revises the course annually, with the goals of integrating the basic science and clinical practice of ophthalmology and of keeping ophthalmologists current with new developments in the various subspecialties.</p>
			<p class="body-text">The BCSC incorporates the effort and expertise of more than 90 ophthalmologists, organized into 13 Section faculties, working with Academy editorial staff. In addition, the course continues to benefit from many lasting contributions made by the faculties of previous editions. Members of the Academy Practicing Ophthalmologists Advisory Committee for Education, Committee on Aging, and Vision Rehabilitation Committee review every volume before major revisions. Members of the European Board of Ophthalmology, organized into Section faculties, also review each volume before major revisions, focusing primarily on differences between American and European ophthalmology practice.</p>
			<p class="fm-only_fm-h2">Organization of the Course</p>
			<p class="body-text--no-indent-">The Basic and Clinical Science Course comprises 13 volumes, incorporating fundamental ophthalmic knowledge, subspecialty areas, and special topics:</p>
			<p class="fm-only_fm-numbered-list-first">&#9;1&#9;Update on General Medicine</p>
			<p class="fm-only_fm-numbered-list-mid">&#9;2&#9;Fundamentals and Principles of Ophthalmology</p>
			<p class="fm-only_fm-numbered-list-mid">&#9;3&#9;Clinical Optics</p>
			<p class="fm-only_fm-numbered-list-mid">&#9;4&#9;Ophthalmic Pathology and Intraocular Tumors</p>
			<p class="fm-only_fm-numbered-list-mid">&#9;5&#9;Neuro-Ophthalmology</p>
			<p class="fm-only_fm-numbered-list-mid">&#9;6&#9;Pediatric Ophthalmology and Strabismus</p>
			<p class="fm-only_fm-numbered-list-mid">&#9;7&#9;Orbit, Eyelids, and Lacrimal System</p>
			<p class="fm-only_fm-numbered-list-mid">&#9;8&#9;External Disease and Cornea</p>
			<p class="fm-only_fm-numbered-list-mid">&#9;9&#9;Intraocular Inflammation and Uveitis</p>
			<p class="fm-only_fm-numbered-list-mid">&#9;10&#9;Glaucoma</p>
			<p class="fm-only_fm-numbered-list-mid">&#9;11&#9;Lens and Cataract</p>
			<p class="fm-only_fm-numbered-list-mid">&#9;12&#9;Retina and Vitreous</p>
			<p class="fm-only_fm-numbered-list-last">&#9;13&#9;Refractive Surgery</p>
			<p class="body-text--no-indent-">In addition, a comprehensive Master Index allows the reader to easily locate subjects throughout the entire series.</p>
			<p class="fm-only_fm-h2">References</p>
			<p class="body-text--no-indent-">Readers who wish to explore specific topics in greater detail may consult the references cited within each chapter and listed in the Basic Texts section at the back of the book. These references are intended to be selective rather than exhaustive, chosen by the BCSC faculty as being important, current, and readily available to residents and practitioners.</p>
			<p class="fm-only_fm-h2">Videos</p>
			<p class="body-text--no-indent-">This edition of Section 5, <span class="CharOverride-8">Neuro-Ophthalmology,</span> includes videos related to topics covered in the book. The videos were selected by members of the BCSC faculty and are available to readers of the print and electronic versions of Section 5 (<a href="http://www.aao.org/bcscvideo_section05">www.aao.org/bcscvideo<br />_section05</a>). Mobile-device users can scan the QR code below (a QR-code reader must already be installed on the device) to access the video content.</p>
			<p class="body-text--no-indent- ParaOverride-8"><img class="_idGenObjectAttribute-3" src="BCSC1718_S05_ch00FM_pi-xvi-web-resources/image/qrcode_S05_video_FM.jpg" alt="" /></p>
			<p class="fm-only_fm-h2">Study Questions and CME Credit</p>
			<p class="body-text--no-indent-">Each volume of the BCSC is designed as an independent study activity for ophthalmology residents and practitioners. The learning objectives for this volume are given on page 1. The text, illustrations, and references provide the information necessary to achieve the objectives; the study questions allow readers to test their understanding of the material and their mastery of the objectives. Physicians who wish to claim CME credit for this educational activity may do so by following the instructions given at the end of the book.</p>
			<p class="fm-only_fm-h2">Conclusion</p>
			<p class="body-text--no-indent-">The Basic and Clinical Science Course has expanded greatly over the years, with the addition of much new text, numerous illustrations, and video content. Recent editions have sought to place greater emphasis on clinical applicability while maintaining a solid foundation in basic science. As with any educational program, it reflects the experience of its authors. As its faculties change and medicine progresses, new viewpoints emerge on controversial subjects and techniques. Not all alternate approaches can be included in this series; as with any educational endeavor, the learner should seek additional sources, including Academy Preferred Practice Pattern Guidelines.</p>
			<p class="body-text">The BCSC faculty and staff continually strive to improve the educational usefulness of the course; you, the reader, can contribute to this ongoing process. If you have any suggestions or questions about the series, please do not hesitate to contact the faculty or the editors.</p>
			<p class="body-text">The authors, editors, and reviewers hope that your study of the BCSC will be of lasting value and that each Section will serve as a practical resource for quality patient care.</p>
		</div>
		<div id="_idContainer015" class="_idGenObjectStyleOverride-1">
			<p class="fm-only_fm-copyright1--pub-info- ParaOverride-9">Copyright © 2017 American Academy of Ophthalmology. All rights reserved. No part of this publication may be reproduced without written permission. </p>
			<p class="fm-only_fm-copyright1--pub-info- ParaOverride-9">Printed in the United States of America.</p>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer016" class="_idGenObjectStyleOverride-3">
			</div>
		</div>
		<div id="_idContainer017" class="_idGenObjectStyleOverride-1">
			<p class="fm-only_fm-copyright2--pub-info-">American Academy of Ophthalmology</p>
			<p class="fm-only_fm-copyright2--pub-info-">655 Beach Street</p>
			<p class="fm-only_fm-copyright2--pub-info-">Box 7424</p>
			<p class="fm-only_fm-copyright2--pub-info-">San Francisco, CA 94120-7424</p>
		</div>
		<div id="_idContainer018" class="_idGenObjectStyleOverride-1">
			<p class="fm-only_fm-title _idGenParaOverride-1">Contents</p>
			<p class="fm-only_fm-toc-fm1">General Introduction&#9;xv</p>
			<p class="fm-only_fm-toc-fm2">Objectives<span class="fm-toc--leader-dots-">&#9;</span>1</p>
			<p class="fm-only_fm-toc-fm2">Introduction<span class="fm-toc--leader-dots-">&#9;</span>3</p>
			<p class="fm-only_fm-toc02"><span class="fm-toc02--num-">&#9;1&#9;</span><a href="">Neuro-Ophthalmic Anatomy<span class="fm-toc--leader-dots-">&#9;</span>5</a></p>
			<p class="fm-only_fm-toc03"><a href="">Bony Anatomy<span class="fm-toc--leader-dots-">&#9;</span>5</a></p>
			<p class="fm-only_fm-toc04"><a href="">Skull Base<span class="fm-toc--leader-dots-">&#9;</span>5</a></p>
			<p class="fm-only_fm-toc04"><a href="">The Orbit<span class="fm-toc--leader-dots-">&#9;</span>6</a></p>
			<p class="fm-only_fm-toc03"><a href="">Vascular Anatomy<span class="fm-toc--leader-dots-">&#9;</span>11</a></p>
			<p class="fm-only_fm-toc04"><a href="">Arterial System<span class="fm-toc--leader-dots-">&#9;</span>11</a></p>
			<p class="fm-only_fm-toc04"><a href="">Venous System<span class="fm-toc--leader-dots-">&#9;</span>21</a></p>
			<p class="fm-only_fm-toc03"><a href="">Afferent Visual Pathways<span class="fm-toc--leader-dots-">&#9;</span>23</a></p>
			<p class="fm-only_fm-toc04"><a href="">Retina<span class="fm-toc--leader-dots-">&#9;</span>23</a></p>
			<p class="fm-only_fm-toc04"><a href="">Optic Nerve<span class="fm-toc--leader-dots-">&#9;</span>26</a></p>
			<p class="fm-only_fm-toc04"><a href="">Optic Chiasm<span class="fm-toc--leader-dots-">&#9;</span>27</a></p>
			<p class="fm-only_fm-toc04"><a href="">Optic Tract<span class="fm-toc--leader-dots-">&#9;</span>28</a></p>
			<p class="fm-only_fm-toc04"><a href="">Cortex<span class="fm-toc--leader-dots-">&#9;</span>29</a></p>
			<p class="fm-only_fm-toc03"><a href="">Efferent Visual System (Ocular Motor Pathways)<span class="fm-toc--leader-dots-">&#9;</span>31</a></p>
			<p class="fm-only_fm-toc04"><a href="">Cortical Input<span class="fm-toc--leader-dots-">&#9;</span>32</a></p>
			<p class="fm-only_fm-toc04"><a href="">Subcortical Structures<span class="fm-toc--leader-dots-">&#9;</span>33</a></p>
			<p class="fm-only_fm-toc04"><a href="">Brainstem<span class="fm-toc--leader-dots-">&#9;</span>34</a></p>
			<p class="fm-only_fm-toc04"><a href="">Ocular Motor Cranial Nerves<span class="fm-toc--leader-dots-">&#9;</span>40</a></p>
			<p class="fm-only_fm-toc04"><a href="">Extraocular Muscles<span class="fm-toc--leader-dots-">&#9;</span>45</a></p>
			<p class="fm-only_fm-toc03"><a href="">Sensory and Facial Motor Anatomy<span class="fm-toc--leader-dots-">&#9;</span>47</a></p>
			<p class="fm-only_fm-toc04"><a href="">Trigeminal Nerve (Fifth Cranial Nerve)<span class="fm-toc--leader-dots-">&#9;</span>47</a></p>
			<p class="fm-only_fm-toc04"><a href="">Facial Nerve (Seventh Cranial Nerve)<span class="fm-toc--leader-dots-">&#9;</span>49</a></p>
			<p class="fm-only_fm-toc04"><a href="">Eyelids<span class="fm-toc--leader-dots-">&#9;</span>52</a></p>
			<p class="fm-only_fm-toc03"><a href="">Ocular Autonomic Pathways<span class="fm-toc--leader-dots-">&#9;</span>52</a></p>
			<p class="fm-only_fm-toc04"><a href="">Sympathetic Pathways<span class="fm-toc--leader-dots-">&#9;</span>52</a></p>
			<p class="fm-only_fm-toc04"><a href="">Parasympathetic Pathways<span class="fm-toc--leader-dots-">&#9;</span>54</a></p>
			<p class="fm-only_fm-toc02"><span class="fm-toc02--num-">&#9;2&#9;</span><a href="">Neuroimaging in Neuro-Ophthalmology<span class="fm-toc--leader-dots-">&#9;</span>57</a></p>
			<p class="fm-only_fm-toc03"><a href="">Introduction<span class="fm-toc--leader-dots-">&#9;</span>57</a></p>
			<p class="fm-only_fm-toc03"><a href="">Computed Tomography<span class="fm-toc--leader-dots-">&#9;</span>60</a></p>
			<p class="fm-only_fm-toc03"><a href="">Magnetic Resonance Imaging<span class="fm-toc--leader-dots-">&#9;</span>60</a></p>
			<p class="fm-only_fm-toc03"><a href="">Vascular Imaging<span class="fm-toc--leader-dots-">&#9;</span>67</a></p>
			<p class="fm-only_fm-toc04"><a href="">Catheter Angiography<span class="fm-toc--leader-dots-">&#9;</span>68</a></p>
			<p class="fm-only_fm-toc04"><a href="">Magnetic Resonance Angiography and Magnetic <br />Resonance Venography<span class="fm-toc--leader-dots-">&#9;</span>68</a></p>
			<p class="fm-only_fm-toc04"><a href="">Computed Tomography Angiography and Computed <br />Tomography Venography<span class="fm-toc--leader-dots-">&#9;</span>69</a></p>
			<p class="fm-only_fm-toc04"><a href="">Metabolic and Functional Imaging Modalities<span class="fm-toc--leader-dots-">&#9;</span>70</a></p>
			<p class="fm-only_fm-toc04"><a href="">Ultrasonography<span class="fm-toc--leader-dots-">&#9;</span>70</a></p>
			<p class="fm-only_fm-toc03"><a href="">Crucial Questions in Imaging<span class="fm-toc--leader-dots-">&#9;</span>71</a></p>
			<p class="fm-only_fm-toc04"><a href="">When to Order<span class="fm-toc--leader-dots-">&#9;</span>71</a></p>
			<p class="fm-only_fm-toc04"><a href="">What to Order<span class="fm-toc--leader-dots-">&#9;</span>71</a></p>
			<p class="fm-only_fm-toc04"><a href="">How to Order<span class="fm-toc--leader-dots-">&#9;</span>73</a></p>
			<p class="fm-only_fm-toc03"><a href="">Negative Study Results<span class="fm-toc--leader-dots-">&#9;</span>73</a></p>
			<p class="fm-only_fm-toc03">Glossary of Select Neuroimaging Terminology<span class="fm-toc--leader-dots-">&#9;</span>75</p>
			<p class="fm-only_fm-toc02"><span class="fm-toc02--num-">&#9;3&#9;</span><a href="">The Patient With Decreased Vision: Evaluation<span class="fm-toc--leader-dots-">&#9;</span>77</a></p>
			<p class="fm-only_fm-toc03"><a href="">History<span class="fm-toc--leader-dots-">&#9;</span>77</a></p>
			<p class="fm-only_fm-toc04"><a href="">Unilateral Versus Bilateral Involvement<span class="fm-toc--leader-dots-">&#9;</span>77</a></p>
			<p class="fm-only_fm-toc04"><a href="">Time Course of Vision Loss<span class="fm-toc--leader-dots-">&#9;</span>77</a></p>
			<p class="fm-only_fm-toc04"><a href="">Associated Symptoms<span class="fm-toc--leader-dots-">&#9;</span>78</a></p>
			<p class="fm-only_fm-toc03"><a href="">Examination<span class="fm-toc--leader-dots-">&#9;</span>78</a></p>
			<p class="fm-only_fm-toc04"><a href="">Visual Acuity Testing<span class="fm-toc--leader-dots-">&#9;</span>78</a></p>
			<p class="fm-only_fm-toc04"><a href="">Color Vision Testing<span class="fm-toc--leader-dots-">&#9;</span>78</a></p>
			<p class="fm-only_fm-toc04"><a href="">Pupillary Testing<span class="fm-toc--leader-dots-">&#9;</span>79</a></p>
			<p class="fm-only_fm-toc04"><a href="">Fundus Examination<span class="fm-toc--leader-dots-">&#9;</span>81</a></p>
			<p class="fm-only_fm-toc04"><a href="">Visual Field Evaluation<span class="fm-toc--leader-dots-">&#9;</span>83</a></p>
			<p class="fm-only_fm-toc04"><a href="">Adjunct Testing<span class="fm-toc--leader-dots-">&#9;</span>88</a></p>
			<p class="fm-only_fm-toc02"><span class="fm-toc02--num-">&#9;</span><a href=""><span class="fm-toc02--num-">4</span></a><span class="fm-toc02--num-">&#9;</span><a href="">The Patient With Decreased Vision: <br />Classification and Management<span class="fm-toc--leader-dots-">&#9;</span>99</a></p>
			<p class="fm-only_fm-toc03"><a href="">Ocular Media Abnormality<span class="fm-toc--leader-dots-">&#9;</span>99</a></p>
			<p class="fm-only_fm-toc03"><a href="">Retinopathy<span class="fm-toc--leader-dots-">&#9;</span>99</a></p>
			<p class="fm-only_fm-toc04"><a href="">Acute Idiopathic Blind-Spot Enlargement, Acute Zonal <br />Occult Outer Retinopathy, and Multiple Evanescent <br />White Dot Syndrome<span class="fm-toc--leader-dots-">&#9;</span>100</a></p>
			<p class="fm-only_fm-toc04"><a href="">Cone Dystrophy<span class="fm-toc--leader-dots-">&#9;</span>102</a></p>
			<p class="fm-only_fm-toc04"><a href="">Autoimmune Retinopathies and Paraneoplastic Retinopathies<span class="fm-toc--leader-dots-">&#9;</span>102</a></p>
			<p class="fm-only_fm-toc03"><a href="">Optic Neuropathy<span class="fm-toc--leader-dots-">&#9;</span>103</a></p>
			<p class="fm-only_fm-toc04"><a href="">Visual Field Patterns in Optic Neuropathy<span class="fm-toc--leader-dots-">&#9;</span>103</a></p>
			<p class="fm-only_fm-toc04"><a href="">Causes of Optic Neuropathy<span class="fm-toc--leader-dots-">&#9;</span>104</a></p>
			<p class="fm-only_fm-toc04"><a href="">Optic Atrophy<span class="fm-toc--leader-dots-">&#9;</span>145</a></p>
			<p class="fm-only_fm-toc03"><a href="">Chiasmal Lesions<span class="fm-toc--leader-dots-">&#9;</span>146</a></p>
			<p class="fm-only_fm-toc04"><a href="">Visual Field Loss Patterns<span class="fm-toc--leader-dots-">&#9;</span>146</a></p>
			<p class="fm-only_fm-toc04"><a href="">Etiology of Chiasmal Disorders<span class="fm-toc--leader-dots-">&#9;</span>147</a></p>
			<p class="fm-only_fm-toc03"><a href="">Retrochiasmal Lesions<span class="fm-toc--leader-dots-">&#9;</span>152</a></p>
			<p class="fm-only_fm-toc04"><a href="">Optic Tract<span class="fm-toc--leader-dots-">&#9;</span>153</a></p>
			<p class="fm-only_fm-toc04"><a href="">Lateral Geniculate Body<span class="fm-toc--leader-dots-">&#9;</span>154</a></p>
			<p class="fm-only_fm-toc04"><a href="">Temporal Lobe<span class="fm-toc--leader-dots-">&#9;</span>155</a></p>
			<p class="fm-only_fm-toc04"><a href="">Parietal Lobe<span class="fm-toc--leader-dots-">&#9;</span>156</a></p>
			<p class="fm-only_fm-toc04"><a href="">Occipital Lobe<span class="fm-toc--leader-dots-">&#9;</span>156</a></p>
			<p class="fm-only_fm-toc03"><a href="">Vision Rehabilitation<span class="fm-toc--leader-dots-">&#9;</span>159</a></p>
			<p class="fm-only_fm-toc02"><span class="fm-toc02--num-">&#9;</span><a href=""><span class="fm-toc02--num-">5</span></a><span class="fm-toc02--num-">&#9;</span><a href="">The Patient With Transient Visual&#160;Loss<span class="fm-toc--leader-dots-">&#9;</span>161</a></p>
			<p class="fm-only_fm-toc03"><a href="">Examination<span class="fm-toc--leader-dots-">&#9;</span>163</a></p>
			<p class="fm-only_fm-toc03"><a href="">Transient Monocular Visual Loss<span class="fm-toc--leader-dots-">&#9;</span>163</a></p>
			<p class="fm-only_fm-toc04"><a href="">Ocular Causes<span class="fm-toc--leader-dots-">&#9;</span>163</a></p>
			<p class="fm-only_fm-toc04"><a href="">Orbital Causes<span class="fm-toc--leader-dots-">&#9;</span>164</a></p>
			<p class="fm-only_fm-toc04"><a href="">Vascular Causes<span class="fm-toc--leader-dots-">&#9;</span>164</a></p>
			<p class="fm-only_fm-toc03"><a href="">Binocular Transient Visual Loss<span class="fm-toc--leader-dots-">&#9;</span>171</a></p>
			<p class="fm-only_fm-toc04"><a href="">Migraine<span class="fm-toc--leader-dots-">&#9;</span>171</a></p>
			<p class="fm-only_fm-toc04"><a href="">Occipital Mass Lesions<span class="fm-toc--leader-dots-">&#9;</span>172</a></p>
			<p class="fm-only_fm-toc04"><a href="">Occipital Ischemia<span class="fm-toc--leader-dots-">&#9;</span>172</a></p>
			<p class="fm-only_fm-toc04"><a href="">Occipital Seizures<span class="fm-toc--leader-dots-">&#9;</span>172</a></p>
			<p class="fm-only_fm-toc02"><span class="fm-toc02--num-">&#9;</span><a href=""><span class="fm-toc02--num-">6</span></a><span class="fm-toc02--num-">&#9;</span><a href="">The Patient With Illusions, Hallucinations, <br />and Disorders of&#160;Higher Cortical Function<span class="fm-toc--leader-dots-">&#9;</span>173</a></p>
			<p class="fm-only_fm-toc03"><a href="">The Patient With Visual Illusions and Distortions<span class="fm-toc--leader-dots-">&#9;</span>173</a></p>
			<p class="fm-only_fm-toc04"><a href="">Ocular Origin<span class="fm-toc--leader-dots-">&#9;</span>174</a></p>
			<p class="fm-only_fm-toc04"><a href="">Optic Nerve Origin<span class="fm-toc--leader-dots-">&#9;</span>175</a></p>
			<p class="fm-only_fm-toc04"><a href="">Cortical Origin<span class="fm-toc--leader-dots-">&#9;</span>175</a></p>
			<p class="fm-only_fm-toc03"><a href="">The Patient With Hallucinations<span class="fm-toc--leader-dots-">&#9;</span>175</a></p>
			<p class="fm-only_fm-toc04"><a href="">Ocular Origin<span class="fm-toc--leader-dots-">&#9;</span>175</a></p>
			<p class="fm-only_fm-toc04"><a href="">Optic Nerve Origin<span class="fm-toc--leader-dots-">&#9;</span>176</a></p>
			<p class="fm-only_fm-toc04"><a href="">Cortical Origin<span class="fm-toc--leader-dots-">&#9;</span>176</a></p>
			<p class="fm-only_fm-toc03"><a href="">The Patient With Disorders of Higher Cortical Function<span class="fm-toc--leader-dots-">&#9;</span>178</a></p>
			<p class="fm-only_fm-toc04"><a href="">Disorders of Recognition<span class="fm-toc--leader-dots-">&#9;</span>179</a></p>
			<p class="fm-only_fm-toc04"><a href="">Disorders of Visual-Spatial Relationships<span class="fm-toc--leader-dots-">&#9;</span>180</a></p>
			<p class="fm-only_fm-toc04"><a href="">Disorders of Awareness of Vision or Visual Deficit<span class="fm-toc--leader-dots-">&#9;</span>180</a></p>
			<p class="fm-only_fm-toc02"><span class="fm-toc02--num-">&#9;</span><a href=""><span class="fm-toc02--num-">7</span></a><span class="fm-toc02--num-">&#9;</span><a href="">The Patient With Abnormal Ocular Motility <br />or Diplopia<span class="fm-toc--leader-dots-">&#9;</span>183</a></p>
			<p class="fm-only_fm-toc03"><a href="">History<span class="fm-toc--leader-dots-">&#9;</span>183</a></p>
			<p class="fm-only_fm-toc03"><a href="">Physical Examination<span class="fm-toc--leader-dots-">&#9;</span>184</a></p>
			<p class="fm-only_fm-toc03"><a href="">Monocular Diplopia<span class="fm-toc--leader-dots-">&#9;</span>185</a></p>
			<p class="fm-only_fm-toc03"><a href="">Differentiating Paretic From Restrictive Etiologies of Diplopia<span class="fm-toc--leader-dots-">&#9;</span>186</a></p>
			<p class="fm-only_fm-toc03"><a href="">Comitant and Incomitant Deviations<span class="fm-toc--leader-dots-">&#9;</span>186</a></p>
			<p class="fm-only_fm-toc03"><a href="">Localization<span class="fm-toc--leader-dots-">&#9;</span>187</a></p>
			<p class="fm-only_fm-toc03"><a href="">Supranuclear Causes of Abnormal Ocular Motility<span class="fm-toc--leader-dots-">&#9;</span>188</a></p>
			<p class="fm-only_fm-toc03"><a href="">Nuclear Causes of Diplopia<span class="fm-toc--leader-dots-">&#9;</span>188</a></p>
			<p class="fm-only_fm-toc03"><a href="">Internuclear Causes of Diplopia<span class="fm-toc--leader-dots-">&#9;</span>189</a></p>
			<p class="fm-only_fm-toc04"><a href="">Internuclear Ophthalmoplegia<span class="fm-toc--leader-dots-">&#9;</span>189</a></p>
			<p class="fm-only_fm-toc04"><a href="">One-and-a-Half Syndrome<span class="fm-toc--leader-dots-">&#9;</span>191</a></p>
			<p class="fm-only_fm-toc03"><a href="">Infranuclear Causes of Diplopia<span class="fm-toc--leader-dots-">&#9;</span>191</a></p>
			<p class="fm-only_fm-toc04"><a href="">Third Cranial Nerve Palsy<span class="fm-toc--leader-dots-">&#9;</span>193</a></p>
			<p class="fm-only_fm-toc04"><a href="">Fourth Cranial Nerve Palsy<span class="fm-toc--leader-dots-">&#9;</span>198</a></p>
			<p class="fm-only_fm-toc04"><a href="">Sixth Cranial Nerve Palsy<span class="fm-toc--leader-dots-">&#9;</span>200</a></p>
			<p class="fm-only_fm-toc04"><a href="">Ocular Neuromyotonia<span class="fm-toc--leader-dots-">&#9;</span>202</a></p>
			<p class="fm-only_fm-toc04"><a href="">Paresis of More Than One Cranial Nerve<span class="fm-toc--leader-dots-">&#9;</span>202</a></p>
			<p class="fm-only_fm-toc04"><a href="">Cavernous Sinus and Superior Orbital Fissure Involvement<span class="fm-toc--leader-dots-">&#9;</span>202</a></p>
			<p class="fm-only_fm-toc04"><a href="">Neuromuscular Junction Causes of Diplopia<span class="fm-toc--leader-dots-">&#9;</span>206</a></p>
			<p class="fm-only_fm-toc03"><a href="">Myopathic, Restrictive, Orbital, and Other Causes of Diplopia<span class="fm-toc--leader-dots-">&#9;</span>206</a></p>
			<p class="fm-only_fm-toc04"><a href="">Thyroid Eye Disease<span class="fm-toc--leader-dots-">&#9;</span>206</a></p>
			<p class="fm-only_fm-toc04"><a href="">Posttraumatic Restriction<span class="fm-toc--leader-dots-">&#9;</span>206</a></p>
			<p class="fm-only_fm-toc04"><a href="">Postsurgical Restriction<span class="fm-toc--leader-dots-">&#9;</span>207</a></p>
			<p class="fm-only_fm-toc04"><a href="">Orbital Myositis<span class="fm-toc--leader-dots-">&#9;</span>207</a></p>
			<p class="fm-only_fm-toc04"><a href="">Chronic Progressive External Ophthalmoplegia<span class="fm-toc--leader-dots-">&#9;</span>208</a></p>
			<p class="fm-only_fm-toc04"><a href="">Neoplastic Involvement<span class="fm-toc--leader-dots-">&#9;</span>208</a></p>
			<p class="fm-only_fm-toc04"><a href="">Brown Syndrome<span class="fm-toc--leader-dots-">&#9;</span>208</a></p>
			<p class="fm-only_fm-toc04"><a href="">Heavy Eye Syndrome<span class="fm-toc--leader-dots-">&#9;</span>208</a></p>
			<p class="fm-only_fm-toc04"><a href="">Sagging Eye Syndrome<span class="fm-toc--leader-dots-">&#9;</span>209</a></p>
			<p class="fm-only_fm-toc04"><a href="">Refractive Procedure–Induced Diplopia<span class="fm-toc--leader-dots-">&#9;</span>209</a></p>
			<p class="fm-only_fm-toc04"><a href="">Foveal Displacement Syndrome<span class="fm-toc--leader-dots-">&#9;</span>209</a></p>
			<p class="fm-only_fm-toc02"><span class="fm-toc02--num-">&#9;8&#9;</span><a href="">The Patient With Supranuclear Disorders <br />of Ocular Motility<span class="fm-toc--leader-dots-">&#9;</span>211</a></p>
			<p class="fm-only_fm-toc03"><a href="">Fundamental Principles of Ocular Motor Control<span class="fm-toc--leader-dots-">&#9;</span>212</a></p>
			<p class="fm-only_fm-toc03"><a href="">Supranuclear Ocular Motor Systems: Function, Anatomy, <br />Clinical&#160;Testing, and Disorders of Eye Movements<span class="fm-toc--leader-dots-">&#9;</span>213</a></p>
			<p class="fm-only_fm-toc04"><a href="">Ocular Fixation System<span class="fm-toc--leader-dots-">&#9;</span>213</a></p>
			<p class="fm-only_fm-toc04"><a href="">Vestibular-Ocular System (Vestibular-Ocular Reflex)<span class="fm-toc--leader-dots-">&#9;</span>214</a></p>
			<p class="fm-only_fm-toc04"><a href="">Optokinetic System (Optokinetic Nystagmus)<span class="fm-toc--leader-dots-">&#9;</span>218</a></p>
			<p class="fm-only_fm-toc04"><a href="">Saccadic System<span class="fm-toc--leader-dots-">&#9;</span>219</a></p>
			<p class="fm-only_fm-toc04"><a href="">Smooth-Pursuit System<span class="fm-toc--leader-dots-">&#9;</span>224</a></p>
			<p class="fm-only_fm-toc04"><a href="">Vergence System<span class="fm-toc--leader-dots-">&#9;</span>226</a></p>
			<p class="fm-only_fm-toc04"><a href="">Gaze Preference, Gaze Palsy, and Tonic Deviations<span class="fm-toc--leader-dots-">&#9;</span>228</a></p>
			<p class="fm-only_fm-toc02"><span class="fm-toc02--num-">&#9;</span><a href=""><span class="fm-toc02--num-">9</span></a><span class="fm-toc02--num-">&#9;</span><a href="">The Patient With Nystagmus or Spontaneous <br />Eye Movement Disorders<span class="fm-toc--leader-dots-">&#9;</span>233</a></p>
			<p class="fm-only_fm-toc03"><a href="">Introduction<span class="fm-toc--leader-dots-">&#9;</span>233</a></p>
			<p class="fm-only_fm-toc03"><a href="">Early-Onset (Childhood) Nystagmus<span class="fm-toc--leader-dots-">&#9;</span>235</a></p>
			<p class="fm-only_fm-toc04"><a href="">Infantile Nystagmus Syndrome (Congenital Nystagmus)<span class="fm-toc--leader-dots-">&#9;</span>235</a></p>
			<p class="fm-only_fm-toc04"><a href="">Fusional Maldevelopment Nystagmus Syndrome (Latent <br />Nystagmus)<span class="fm-toc--leader-dots-">&#9;</span>237</a></p>
			<p class="fm-only_fm-toc04"><a href="">Heimann-Bielschowsky Phenomenon<span class="fm-toc--leader-dots-">&#9;</span>238</a></p>
			<p class="fm-only_fm-toc04"><a href="">Spasmus Nutans Syndrome<span class="fm-toc--leader-dots-">&#9;</span>239</a></p>
			<p class="fm-only_fm-toc03"><a href="">Gaze-Evoked Nystagmus<span class="fm-toc--leader-dots-">&#9;</span>240</a></p>
			<p class="fm-only_fm-toc04"><a href="">Rebound Nystagmus<span class="fm-toc--leader-dots-">&#9;</span>240</a></p>
			<p class="fm-only_fm-toc03"><a href="">Vestibular Nystagmus<span class="fm-toc--leader-dots-">&#9;</span>241</a></p>
			<p class="fm-only_fm-toc04"><a href="">Peripheral Vestibular Nystagmus<span class="fm-toc--leader-dots-">&#9;</span>241</a></p>
			<p class="fm-only_fm-toc04"><a href="">Central Forms of Vestibular Nystagmus<span class="fm-toc--leader-dots-">&#9;</span>243</a></p>
			<p class="fm-only_fm-toc03"><a href="">Acquired Pendular Nystagmus<span class="fm-toc--leader-dots-">&#9;</span>246</a></p>
			<p class="fm-only_fm-toc04"><a href="">Oculopalatal Myoclonus or Tremor<span class="fm-toc--leader-dots-">&#9;</span>246</a></p>
			<p class="fm-only_fm-toc03"><a href="">See-Saw Nystagmus<span class="fm-toc--leader-dots-">&#9;</span>247</a></p>
			<p class="fm-only_fm-toc03"><a href="">Dissociated Nystagmus With Internuclear Ophthalmoplegia<span class="fm-toc--leader-dots-">&#9;</span>247</a></p>
			<p class="fm-only_fm-toc03"><a href="">Saccadic Intrusions<span class="fm-toc--leader-dots-">&#9;</span>247</a></p>
			<p class="fm-only_fm-toc04"><a href="">Saccadic Intrusions With Normal Intersaccadic Intervals<span class="fm-toc--leader-dots-">&#9;</span>247</a></p>
			<p class="fm-only_fm-toc04"><a href="">Saccadic Intrusions Without Normal Intersaccadic Intervals<span class="fm-toc--leader-dots-">&#9;</span>248</a></p>
			<p class="fm-only_fm-toc04"><a href="">Voluntary Flutter (Voluntary “Nystagmus”)<span class="fm-toc--leader-dots-">&#9;</span>249</a></p>
			<p class="fm-only_fm-toc03"><a href="">Additional Eye Movement Disorders<span class="fm-toc--leader-dots-">&#9;</span>250</a></p>
			<p class="fm-only_fm-toc04"><a href="">Convergence-Retraction Nystagmus<span class="fm-toc--leader-dots-">&#9;</span>250</a></p>
			<p class="fm-only_fm-toc04"><a href="">Superior Oblique Myokymia<span class="fm-toc--leader-dots-">&#9;</span>250</a></p>
			<p class="fm-only_fm-toc04"><a href="">Oculomasticatory Myorhythmia<span class="fm-toc--leader-dots-">&#9;</span>251</a></p>
			<p class="fm-only_fm-toc02"><span class="fm-toc02--num-">&#9;10&#9;</span><a href="">The Patient With Pupillary Abnormalities<span class="fm-toc--leader-dots-">&#9;</span>253</a></p>
			<p class="fm-only_fm-toc03"><a href="">History<span class="fm-toc--leader-dots-">&#9;</span>253</a></p>
			<p class="fm-only_fm-toc03"><a href="">Pupillary Examination<span class="fm-toc--leader-dots-">&#9;</span>253</a></p>
			<p class="fm-only_fm-toc03"><a href="">Baseline Pupil Size<span class="fm-toc--leader-dots-">&#9;</span>254</a></p>
			<p class="fm-only_fm-toc03"><a href="">Pupil Irregularity<span class="fm-toc--leader-dots-">&#9;</span>255</a></p>
			<p class="fm-only_fm-toc03"><a href="">Anisocoria<span class="fm-toc--leader-dots-">&#9;</span>255</a></p>
			<p class="fm-only_fm-toc04"><a href="">Normal Pupillary Response to Light<span class="fm-toc--leader-dots-">&#9;</span>255</a></p>
			<p class="fm-only_fm-toc04"><a href="">Anisocoria Equal in Dim and Bright Light<span class="fm-toc--leader-dots-">&#9;</span>257</a></p>
			<p class="fm-only_fm-toc04"><a href="">Anisocoria Greater in Dim Light<span class="fm-toc--leader-dots-">&#9;</span>257</a></p>
			<p class="fm-only_fm-toc04"><a href="">Anisocoria Greater in Bright Light<span class="fm-toc--leader-dots-">&#9;</span>262</a></p>
			<p class="fm-only_fm-toc03"><a href="">Disorders of Pupillary Reactivity: Light–Near Dissociation<span class="fm-toc--leader-dots-">&#9;</span>266</a></p>
			<p class="fm-only_fm-toc04"><a href="">Afferent Visual Pathway<span class="fm-toc--leader-dots-">&#9;</span>266</a></p>
			<p class="fm-only_fm-toc04"><a href="">Midbrain<span class="fm-toc--leader-dots-">&#9;</span>266</a></p>
			<p class="fm-only_fm-toc04"><a href="">Aberrant Regeneration<span class="fm-toc--leader-dots-">&#9;</span>267</a></p>
			<p class="fm-only_fm-toc03"><a href="">Other Pupillary Disorders<span class="fm-toc--leader-dots-">&#9;</span>267</a></p>
			<p class="fm-only_fm-toc04"><a href="">Benign Episodic Unilateral Mydriasis<span class="fm-toc--leader-dots-">&#9;</span>267</a></p>
			<p class="fm-only_fm-toc02"><span class="fm-toc02--num-">&#9;11&#9;</span><a href="">The Patient With Eyelid or Facial Abnormalities<span class="fm-toc--leader-dots-">&#9;</span>269</a></p>
			<p class="fm-only_fm-toc03"><a href="">Examination Techniques<span class="fm-toc--leader-dots-">&#9;</span>269</a></p>
			<p class="fm-only_fm-toc03"><a href="">Ptosis<span class="fm-toc--leader-dots-">&#9;</span>272</a></p>
			<p class="fm-only_fm-toc04"><a href="">Congenital Ptosis<span class="fm-toc--leader-dots-">&#9;</span>272</a></p>
			<p class="fm-only_fm-toc04"><a href="">Acquired Ptosis<span class="fm-toc--leader-dots-">&#9;</span>273</a></p>
			<p class="fm-only_fm-toc04"><a href="">Pseudoptosis<span class="fm-toc--leader-dots-">&#9;</span>274</a></p>
			<p class="fm-only_fm-toc04"><a href="">Apraxia of Eyelid Opening<span class="fm-toc--leader-dots-">&#9;</span>274</a></p>
			<p class="fm-only_fm-toc03"><a href="">Eyelid Retraction<span class="fm-toc--leader-dots-">&#9;</span>274</a></p>
			<p class="fm-only_fm-toc03"><a href="">Abnormalities of Facial Movement<span class="fm-toc--leader-dots-">&#9;</span>275</a></p>
			<p class="fm-only_fm-toc03"><a href="">Seventh Cranial Nerve Disorders<span class="fm-toc--leader-dots-">&#9;</span>277</a></p>
			<p class="fm-only_fm-toc04"><a href="">Disorders of Underactivity of the Seventh Cranial Nerve<span class="fm-toc--leader-dots-">&#9;</span>277</a></p>
			<p class="fm-only_fm-toc04"><a href="">Disorders of Overactivity of the Seventh Cranial Nerve<span class="fm-toc--leader-dots-">&#9;</span>281</a></p>
			<p class="fm-only_fm-toc02"><span class="fm-toc02--num-">&#9;</span><a href=""><span class="fm-toc02--num-">12</span></a><span class="fm-toc02--num-">&#9;</span><a href="">The Patient With Head, Ocular, or&#160;Facial Pain<span class="fm-toc--leader-dots-">&#9;</span>287</a></p>
			<p class="fm-only_fm-toc03"><a href="">Head Pain<span class="fm-toc--leader-dots-">&#9;</span>287</a></p>
			<p class="fm-only_fm-toc04"><a href="">Migraine and Tension-type Headache<span class="fm-toc--leader-dots-">&#9;</span>288</a></p>
			<p class="fm-only_fm-toc04"><a href="">Trigeminal Autonomic Cephalgias and Hemicrania Continua<span class="fm-toc--leader-dots-">&#9;</span>293</a></p>
			<p class="fm-only_fm-toc04"><a href="">Idiopathic Stabbing Headache<span class="fm-toc--leader-dots-">&#9;</span>294</a></p>
			<p class="fm-only_fm-toc04"><a href="">Inherited Encephalopathies Resembling Migraine<span class="fm-toc--leader-dots-">&#9;</span>294</a></p>
			<p class="fm-only_fm-toc03"><a href="">Ocular and Orbital Pain<span class="fm-toc--leader-dots-">&#9;</span>295</a></p>
			<p class="fm-only_fm-toc04"><a href="">Trochlear Headache and Trochleitis<span class="fm-toc--leader-dots-">&#9;</span>296</a></p>
			<p class="fm-only_fm-toc04"><a href="">Photophobia<span class="fm-toc--leader-dots-">&#9;</span>296</a></p>
			<p class="fm-only_fm-toc03"><a href="">Facial Pain<span class="fm-toc--leader-dots-">&#9;</span>296</a></p>
			<p class="fm-only_fm-toc04"><a href="">Trigeminal Neuralgia<span class="fm-toc--leader-dots-">&#9;</span>297</a></p>
			<p class="fm-only_fm-toc04"><a href="">Occipital Neuralgia<span class="fm-toc--leader-dots-">&#9;</span>297</a></p>
			<p class="fm-only_fm-toc04"><a href="">Temporomandibular Disease<span class="fm-toc--leader-dots-">&#9;</span>297</a></p>
			<p class="fm-only_fm-toc04"><a href="">Internal Carotid Artery Dissection<span class="fm-toc--leader-dots-">&#9;</span>297</a></p>
			<p class="fm-only_fm-toc04"><a href="">Herpes Zoster Ophthalmicus<span class="fm-toc--leader-dots-">&#9;</span>298</a></p>
			<p class="fm-only_fm-toc04"><a href="">Neoplastic Processes<span class="fm-toc--leader-dots-">&#9;</span>298</a></p>
			<p class="fm-only_fm-toc02"><span class="fm-toc02--num-">&#9;</span><a href=""><span class="fm-toc02--num-">13</span></a><span class="fm-toc02--num-">&#9;</span><a href="">The Patient With Nonorganic Ophthalmic <br />Disorders<span class="fm-toc--leader-dots-">&#9;</span>299</a></p>
			<p class="fm-only_fm-toc03"><a href="">Clinical Profile<span class="fm-toc--leader-dots-">&#9;</span>300</a></p>
			<p class="fm-only_fm-toc03"><a href="">Examination Techniques<span class="fm-toc--leader-dots-">&#9;</span>301</a></p>
			<p class="fm-only_fm-toc04"><a href="">Afferent Visual Pathway<span class="fm-toc--leader-dots-">&#9;</span>301</a></p>
			<p class="fm-only_fm-toc04"><a href="">Ocular Motility and Alignment<span class="fm-toc--leader-dots-">&#9;</span>309</a></p>
			<p class="fm-only_fm-toc04"><a href="">Pupils and Accommodation<span class="fm-toc--leader-dots-">&#9;</span>310</a></p>
			<p class="fm-only_fm-toc04"><a href="">Eyelid Position and Function<span class="fm-toc--leader-dots-">&#9;</span>310</a></p>
			<p class="fm-only_fm-toc03"><a href="">Management of the Patient With Nonorganic <br />Ophthalmic Disorders<span class="fm-toc--leader-dots-">&#9;</span>311</a></p>
			<p class="fm-only_fm-toc02"><span class="fm-toc02--num-">&#9;</span><a href=""><span class="fm-toc02--num-">14</span></a><span class="fm-toc02--num-">&#9;</span><a href="">Selected Systemic Conditions With <br />Neuro-Ophthalmic Signs<span class="fm-toc--leader-dots-">&#9;</span>313</a></p>
			<p class="fm-only_fm-toc03"><a href="">Immunologic Disorders<span class="fm-toc--leader-dots-">&#9;</span>313</a></p>
			<p class="fm-only_fm-toc04"><a href="">Giant Cell Arteritis<span class="fm-toc--leader-dots-">&#9;</span>313</a></p>
			<p class="fm-only_fm-toc04"><a href="">Multiple Sclerosis<span class="fm-toc--leader-dots-">&#9;</span>315</a></p>
			<p class="fm-only_fm-toc04"><a href="">Neuromyelitis Optica<span class="fm-toc--leader-dots-">&#9;</span>320</a></p>
			<p class="fm-only_fm-toc04"><a href="">Myasthenia Gravis<span class="fm-toc--leader-dots-">&#9;</span>323</a></p>
			<p class="fm-only_fm-toc04"><a href="">Thyroid Eye Disease<span class="fm-toc--leader-dots-">&#9;</span>326</a></p>
			<p class="fm-only_fm-toc04"><a href="">Sarcoidosis<span class="fm-toc--leader-dots-">&#9;</span>327</a></p>
			<p class="fm-only_fm-toc03"><a href="">Inherited Disorders With Neuro-Ophthalmic Signs<span class="fm-toc--leader-dots-">&#9;</span>328</a></p>
			<p class="fm-only_fm-toc04"><a href="">Myopathies<span class="fm-toc--leader-dots-">&#9;</span>328</a></p>
			<p class="fm-only_fm-toc04"><a href="">Neurocutaneous Syndromes<span class="fm-toc--leader-dots-">&#9;</span>330</a></p>
			<p class="fm-only_fm-toc03"><a href="">Selected Neuro-Ophthalmic Disorders Associated <br />With Pregnancy<span class="fm-toc--leader-dots-">&#9;</span>333</a></p>
			<p class="fm-only_fm-toc04"><a href="">Posterior Reversible Encephalopathy Syndrome<span class="fm-toc--leader-dots-">&#9;</span>333</a></p>
			<p class="fm-only_fm-toc04"><a href="">Lymphocytic Hypophysitis<span class="fm-toc--leader-dots-">&#9;</span>335</a></p>
			<p class="fm-only_fm-toc03"><a href="">Cerebrovascular Disorders<span class="fm-toc--leader-dots-">&#9;</span>335</a></p>
			<p class="fm-only_fm-toc04"><a href="">Transient Visual Loss<span class="fm-toc--leader-dots-">&#9;</span>336</a></p>
			<p class="fm-only_fm-toc04"><a href="">Vertebrobasilar System Disease<span class="fm-toc--leader-dots-">&#9;</span>336</a></p>
			<p class="fm-only_fm-toc04"><a href="">Cerebral Aneurysms<span class="fm-toc--leader-dots-">&#9;</span>338</a></p>
			<p class="fm-only_fm-toc04"><a href="">Arterial Dissection<span class="fm-toc--leader-dots-">&#9;</span>342</a></p>
			<p class="fm-only_fm-toc04"><a href="">Arteriovenous Malformations<span class="fm-toc--leader-dots-">&#9;</span>343</a></p>
			<p class="fm-only_fm-toc04"><a href="">Cerebral Venous Thrombosis<span class="fm-toc--leader-dots-">&#9;</span>345</a></p>
			<p class="fm-only_fm-toc04"><a href="">Reversible Cerebral Vasoconstriction Syndrome<span class="fm-toc--leader-dots-">&#9;</span>346</a></p>
			<p class="fm-only_fm-toc03"><a href="">Neuro-Ophthalmic Manifestations of Infectious Diseases<span class="fm-toc--leader-dots-">&#9;</span>348</a></p>
			<p class="fm-only_fm-toc04"><a href="">Human Immunodeficiency Virus Infection<span class="fm-toc--leader-dots-">&#9;</span>348</a></p>
			<p class="fm-only_fm-toc04"><a href="">Herpesvirus<span class="fm-toc--leader-dots-">&#9;</span>350</a></p>
			<p class="fm-only_fm-toc04"><a href="">Mycobacterium<span class="fm-toc--leader-dots-">&#9;</span>350</a></p>
			<p class="fm-only_fm-toc04"><a href="">Syphilis<span class="fm-toc--leader-dots-">&#9;</span>351</a></p>
			<p class="fm-only_fm-toc04"><a href="">Progressive Multifocal Leukoencephalopathy<span class="fm-toc--leader-dots-">&#9;</span>351</a></p>
			<p class="fm-only_fm-toc04"><a href="">Toxoplasmosis<span class="fm-toc--leader-dots-">&#9;</span>352</a></p>
			<p class="fm-only_fm-toc04"><a href="">Lyme Disease<span class="fm-toc--leader-dots-">&#9;</span>352</a></p>
			<p class="fm-only_fm-toc04"><a href="">Fungal Infections<span class="fm-toc--leader-dots-">&#9;</span>353</a></p>
			<p class="fm-only_fm-toc04"><a href="">Prion Diseases<span class="fm-toc--leader-dots-">&#9;</span>357</a></p>
			<p class="fm-only_fm-toc03"><a href="">Radiation Therapy<span class="fm-toc--leader-dots-">&#9;</span>357</a></p>
			<p class="fm-only_fm-toc-endmatter-first">Basic Texts&#9;359</p>
			<p class="fm-only_fm-toc03">Related Academy Materials&#9;361</p>
			<p class="fm-only_fm-toc03">Requesting Continuing Medical Education Credit&#9;363</p>
			<p class="fm-only_fm-toc03">Study Questions&#9;365</p>
			<p class="fm-only_fm-toc03">Answer Sheet for Section 5 Study Questions&#9;373</p>
			<p class="fm-only_fm-toc03">Answers&#9;375</p>
			<p class="fm-only_fm-toc03">Index&#9;381</p>
		</div>
		<div id="_idContainer019" class="_idGenObjectStyleOverride-1">
			<p class="page-elements_rhv"> <span class="rh-bullet"></span> Contents</p>
		</div>
		<div id="_idContainer020" class="_idGenObjectStyleOverride-1">
			<p class="page-elements_rhr">Contents <span class="rh-bullet">d</span>  </p>
		</div>
		<div id="_idContainer021" class="_idGenObjectStyleOverride-1">
			<p class="page-elements_rhv"> <span class="rh-bullet"></span> Contents</p>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer022" class="Basic-Text-Frame">
			</div>
		</div>
		<div id="_idContainer023" class="_idGenObjectStyleOverride-1">
			<p class="page-elements_rhv"> <span class="rh-bullet"></span> General Introduction</p>
		</div>
	</body>
</html>
